UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 44

Sortiert nach

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

The Lancet (British edition), 2017-12, Vol.390 (10114), p.2779-2789

2017

Link zum Volltext

Verfügbarkeit prüfen

Influence of the Secondary Deployment of Expanded Polytetrafluoroethylene–covered Stent Grafts on Maintenance of Transjugular Intrahepatic Portosystemic Shunt Patency

Journal of vascular and interventional radiology, 2011, Vol.22 (1), p.55-60

2011

Link zum Volltext

Verfügbarkeit prüfen

Endoscopic variceal band ligation compared with propranolol for prophylaxis of first variceal bleeding

Annals of hepatology, 2011-04, Vol.10 (2), p.142-149

2011

Link zum Volltext

Verfügbarkeit prüfen

A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease

PloS one, 2013-03, Vol.8 (3), p.e60094

2013

Link zum Volltext

Verfügbarkeit prüfen

A Global, Prospective, Observational Study Measuring Disease Burden and Suffering in Patients With Ulcerative Colitis, Using the Pictorial Representation of Illness and Self-measure Tool

Journal of Crohn's and colitis, 2021-02, Vol.15 (2), p.228-237

2021

Link zum Volltext

Verfügbarkeit prüfen

Tu1738 – Biomarker and Pharmacokinetic Data from the Turandot Ii Open-Label Extension Study of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 (MADCAM-1) Antibody Shp647 in Patients with Ulcerative Colitis

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-1105-S-1106

2019

Link zum Volltext

Verfügbarkeit prüfen

Su1912 CDEIS SCORE OF 2 IS OPTIMAL CUT-OFF ASSOCIATED WITH LOWER RISK OF DISEASE PROGRESSION IN EARLY CROHN'S DISEASE: DATA FROM THE CALM STUDY

Gastroenterology (New York, N.Y. 1943), 2020-05, Vol.158 (6), p.S-699-S-699

2020

Link zum Volltext

Verfügbarkeit prüfen

Sa1812 – Endoscopic and Deep Remission At 1 Year Prevents Disease Progression in Early Crohn's Disease: Long-Term Data from Calm

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.S-411-S-411

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn's disease and ulcerative colitis

Scandinavian journal of gastroenterology, 2016-09, Vol.51 (9), p.1062-1068

2016

Link zum Volltext

Verfügbarkeit prüfen

718 - Superior Endoscopic and Deep Remission Outcomes in Adults with Moderate to Severe Crohn's Disease Managed with Treat to Target Approach Versus Clinical Symptoms: Data from Calm

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S155-S155

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II

Journal of Crohn's and colitis, 2021-06, Vol.15 (6), p.938-949

2021

Link zum Volltext

Verfügbarkeit prüfen

TIPS Creation in a patient with situs inversus totalis

Cardiovascular and interventional radiology, 2002-09, Vol.25 (5), p.447-449

2002

Link zum Volltext

Verfügbarkeit prüfen

Superior Endoscopic and Deep Remission Outcomes in Adults with Moderate to Severe Crohn's Disease Managed with Treat to Target Approach Versus Clinical Symptoms: Data from Calm

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S155-S155

2017

Link zum Volltext

Verfügbarkeit prüfen

901a A Randomized, Multicenter Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Anti-MAdCAM Antibody PF-00547659 (PF) in Patients With Moderate to Severe Ulcerative Colitis: Results of the TURANDOT Study

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-1193-S-1193

2015

Link zum Volltext

Verfügbarkeit prüfen

Transduodenal intraluminal high dose rate brachytherapy in the treatment of carcinomas of the subhepatic region

Hepato-gastroenterology, 2002-07, Vol.49 (46), p.1045

2002

Link zum Volltext

Verfügbarkeit prüfen

A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohns Disease. e60094

PloS one, 2013-03, Vol.8 (3)

2013

Link zum Volltext

Verfügbarkeit prüfen

Spontaneous bacterial peritonitis in the Czech republic: prevalence and aetiology

European journal of gastroenterology & hepatology, 2003-07, Vol.15 (7), p.739-743

2003

Link zum Volltext

Verfügbarkeit prüfen

Value of Doppler sonography in revealing transjugular intrahepatic portosystemic shunt malfunction: a 5-year experience in 216 patients

American journal of roentgenology (1976), 2000-07, Vol.175 (1), p.141

2000

Link zum Volltext

Verfügbarkeit prüfen

Management of Acute Variceal Bleeding

Digestive Diseases, 2003, Vol.21 (1), p.6-15

2003

Link zum Volltext

Verfügbarkeit prüfen

Spontaneous bacterial peritonitis in the Czech Republic: prevalence and aetiology

European journal of gastroenterology & hepatology, 2003-07, Vol.15 (7), p.739-743

2003

Link zum Volltext

Verfügbarkeit prüfen

Chronic cholestatic liver diseases - Primary biliary cholangitis and Primary sclerosing cholangitis

Vnitřní lékar̆stvĭ, 2020-08, Vol.66 (5), p.287-300

2020

Link zum Volltext

Verfügbarkeit prüfen

Bleeding in portal hypertension

Vnitřní lékar̆stvĭ, 2020-06, Vol.66 (4), p.e7-e16

2020

Link zum Volltext

Verfügbarkeit prüfen

Bleeding in portal hypertension

Vnitřní lékar̆stvĭ, 2020-01, Vol.66 (4), p.32-41

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(44)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(17)
Science & Technology
(17)
Life Sciences & Biomedicine
(16)
Female
(14)
Male
(14)
Aged
(12)
Middle Aged
(12)
Adult
(11)
Gastroenterology & Hepatology
(7)
Treatment Outcome
(7)
Patients
(6)
Adolescent
(5)
Biological And Medical Sciences
(5)
Medical Sciences
(5)
Radiology, Nuclear Medicine & Medical Imaging
(5)
Young Adult
(5)
Inflammatory Bowel Disease
(4)
Aged, 80 And Over
(3)
Clinical Trials
(3)
Crohn Disease - Drug Therapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial

Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial

Influence of the Secondary Deployment of Expanded Polytetrafluoroethylene–covered Stent Grafts on Maintenance of Transjugular Intrahepatic Portosystemic Shunt Patency

Endoscopic variceal band ligation compared with propranolol for prophylaxis of first variceal bleeding

A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease

A Global, Prospective, Observational Study Measuring Disease Burden and Suffering in Patients With Ulcerative Colitis, Using the Pictorial Representation of Illness and Self-measure Tool

Tu1738 – Biomarker and Pharmacokinetic Data from the Turandot Ii Open-Label Extension Study of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 (MADCAM-1) Antibody Shp647 in Patients with Ulcerative Colitis

Su1912 CDEIS SCORE OF 2 IS OPTIMAL CUT-OFF ASSOCIATED WITH LOWER RISK OF DISEASE PROGRESSION IN EARLY CROHN'S DISEASE: DATA FROM THE CALM STUDY

Sa1812 – Endoscopic and Deep Remission At 1 Year Prevents Disease Progression in Early Crohn's Disease: Long-Term Data from Calm

Clinical monitoring: infliximab biosimilar CT-P13 in the treatment of Crohn's disease and ulcerative colitis

A Treat to Target Approach Decreases the Rate of CD-Related Adverse Outcomes versus a Clinical Approach in Patients With Moderate to Severely Active Crohnʼs Disease: Data From CALM 2017 ACG Governors Award for Excellence in Clinical Research: 598

718 - Superior Endoscopic and Deep Remission Outcomes in Adults with Moderate to Severe Crohn's Disease Managed with Treat to Target Approach Versus Clinical Symptoms: Data from Calm

Long-term Safety and Efficacy of the Anti-MAdCAM-1 Monoclonal Antibody Ontamalimab [SHP647] for the Treatment of Ulcerative Colitis: The Open-label Study TURANDOT II

TIPS Creation in a patient with situs inversus totalis

Superior Endoscopic and Deep Remission Outcomes in Adults with Moderate to Severe Crohn's Disease Managed with Treat to Target Approach Versus Clinical Symptoms: Data from Calm

901a A Randomized, Multicenter Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Anti-MAdCAM Antibody PF-00547659 (PF) in Patients With Moderate to Severe Ulcerative Colitis: Results of the TURANDOT Study

Transduodenal intraluminal high dose rate brachytherapy in the treatment of carcinomas of the subhepatic region

A Randomized Controlled Trial of the Efficacy and Safety of CCX282-B, an Orally-Administered Blocker of Chemokine Receptor CCR9, for Patients with Crohns Disease. e60094

Spontaneous bacterial peritonitis in the Czech republic: prevalence and aetiology

Value of Doppler sonography in revealing transjugular intrahepatic portosystemic shunt malfunction: a 5-year experience in 216 patients

Management of Acute Variceal Bleeding

Spontaneous bacterial peritonitis in the Czech Republic: prevalence and aetiology

Chronic cholestatic liver diseases - Primary biliary cholangitis and Primary sclerosing cholangitis

Bleeding in portal hypertension

Bleeding in portal hypertension

Suchergebnisse filtern